Trifecta-Lung cfDNA-MMDx Study
Recruiting in Palo Alto (17 mi)
+8 other locations
PF
Overseen byPhilip F Halloran, MD PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: University of Alberta
No Placebo Group
Trial Summary
What is the purpose of this trial?
Demonstrate the relationship between dd-cfDNA levels and HLA antibodies in blood transplant recipient and Demonstrate the Molecular Microscope® (MMDx) Diagnostic System results in indication and protocol biopsies from lung transplants.
Research Team
PF
Philip F Halloran, MD PhD
Principal Investigator
Alberta Transplant Applied Genomics Centre, University of Alberta
Eligibility Criteria
Inclusion Criteria
Adult, Older adult
Treatment Details
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
BAYLOR SCOTT & WHITE RESEARCH INSTITUTE , 3409 Worth StreetDallas, TX
Division of Pulmonary, Critical Care and Sleep Medicine, University of Florida, College of MedicineGainesville, FL
University Health Network, Toronto General HospitalToronto, Canada
Department of Medicine, University of AlbertaEdmonton, Canada
Loading ...
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor
Trials
957
Patients Recruited
437,000+
One Lambda
Collaborator
Trials
3
Patients Recruited
1,200+
Natera, Inc.
Industry Sponsor
Trials
56
Patients Recruited
50,700+